HC Wainwright Issues Positive Estimate for ALLO Earnings
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for shares of Allogene Therapeutics in a note issued to investors on Wednesday, March 19th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings of ($0.27) per share for […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for shares of Allogene Therapeutics in a note issued to investors on Wednesday, March 19th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings of ($0.27) per share for […]
